Search | Page 16 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

    ... that have not achieved a CR after 2 cycles of induction chemotherapy ; for patients with AML evolving from myelodysplastic syndrome, they should have at least one cycle of induction chemotherapy Research participants must have bone marrow and ...

    Clinical Trial last updated 07/14/2016 - 4:08pm.

  2. Anna Sobon

    ... illnesses and didn’t have hair because of the massive chemotherapy . “When I got back from Seattle, I went into counseling for ...

    "Like You" Patient Story last updated 07/19/2017 - 4:23pm.

  3. Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation

    ... NHL in remission which is considered not curable with chemotherapy alone and not eligible/appropriate for autologous transplant. ... NHL in remission which is considered not curable with chemotherapy alone and not eligible/appropriate for autologous transplant. ...

    Clinical Trial last updated 04/29/2016 - 1:11pm.

  4. Fatigue

    ... muscle function. Other causes may include: Chemotherapy and other medications and treatments Sleep disturbances ...

    Page last updated 02/01/2017 - 11:52am.

  5. Factors affecting response to treatment for secondary MDS and AML

    ... increases in patients who receive multiple rounds of chemotherapy and radiation therapy, and also in those who undergo stem cell ... included surgery (1252 patients), radiation (939 patients), chemotherapy (1211 patients), or observation (124 patients).  Patients whose ...

    Research Review last updated 05/02/2016 - 9:32am.

  6. Allo HSCT Using RIC for Hematological Diseases

    ... in marrow after having failed one or more cycles of chemotherapy . Acute Lymphocytic Leukemia (ALL): factor that define high ... mass greater than 5 cm) should be considered for de-bulking chemotherapy before transplant. Lymphoplasmacytic Lymphoma, Mantle-Cell ...

    Clinical Trial last updated 05/02/2016 - 9:29am.

  7. Clinical Trials Report for November 2015

    ... identifier: NCT02281084 Outpatient Induction Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Advanced ... clinical trial studies the feasibility of having induction chemotherapy in an outpatient setting. Patients with acute leukemia (AML) or ...

    Page last updated 10/30/2015 - 8:46am.

  8. AAMDSIF Summer Fellowship Grant Program

    ... I will test whether the amount of DNA breaks caused by chemotherapy in patient’s blood samples predicts who will respond to ... This could serve as an early marker of who will respond to chemotherapy and could be used in future clinical trials to monitor patients ...

    Page last updated 05/17/2017 - 1:29pm.

  9. Clinical Trials Report for October 2015

    ... identifier: NCT02281084 Outpatient Induction Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Advanced ... clinical trial studies the feasibility of having induction chemotherapy in an outpatient setting. Patients with acute leukemia (AML) or ...

    Page last updated 09/30/2015 - 10:53am.

  10. Safety and Effect of GL-ONC1 Administered IV With or Without Eculizumab Prior to Surgery to Patients With Solid Organ Cancers Undergoing Surgery

    ... but not limited to biological therapy, radiotherapy, chemotherapy , or surgical procedures. Any other surgery (except biopsies) ... agent while on study. Patients who have received chemotherapy or radiotherapy within 4 weeks prior to entering the study or ...

    Clinical Trial last updated 04/28/2016 - 1:57pm.